Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study

Maria Rosaria Valerio, Marco Vella, Carlo Pavone, Vincenzo Serretta, Cristina Scalici Gesolfo, Fabrizio Di Maida, Chiara Sanfilippo, Loris Cacciatore, Davide Baiamonte, Carlo Pavone, Marco Vella, Maria Rosaria Valerio, Vincenzo Serretta, Chiara Carola Sanfilippo, Cristina Scalici Gesolfo, Davide Baiamonte, Loris Cacciatore

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Evidence that smoking cessation at first diagnosis of nonmuscle-invasive bladder cancer (NMIBC) reduces the risk of recurrence is lacking. The aim of our prospective study was to analyze the association between patients' changes in smoking habits after diagnosis and recurrence-free survival (RFS).
Original languageEnglish
Number of pages6
JournalUrologia Internationalis
Publication statusPublished - 2020

All Science Journal Classification (ASJC) codes

  • Urology

Fingerprint

Dive into the research topics of 'Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study'. Together they form a unique fingerprint.

Cite this